Advanced Imaging for Precise Liver Cancer Detection
Glypican-3 (GPC3) Digital PET/CT Scan
A targeted PET/CT scan that binds to Glypican-3 receptors, enabling accuratedetection and characterization of hepatocellular carcinoma (HCC) lesions.
About GPC3 PET/CT Scan
A Glypican-3 (GPC3) PET/CT scan is an advanced molecular imaging technique used for the diagnosis, staging, and treatment planning of hepatocellular carcinoma (HCC), the most common primary liver cancer.
This imaging modality combines two powerful technologies:

Positron Emission Tomography (PET)
detects molecular activity

Positron Emission Tomography (PET)
detects molecular activity
In this procedure, a small amount of a radioactive tracer targeting Glypican-3 (GPC3) is injected into the bloodstream. GPC3 is a cell surface protein that is highly expressed in HCC, while having minimal expression in normal liver tissue.
The PET scan highlights areas of GPC3 expression (tumor activity), while CT precisely localizes these areas anatomically. Together, they provide a highly accurate map of liver tumors, including their size, extent, and spread.
This targeted approach significantly improves tumor detection and supports personalized management of liver cancer patients.
Why is a GPC3 PET/CT Scan Performed?
GPC3 PET/CT plays a crucial role in the evaluation of hepatocellular carcinoma. Key
clinical applications include:
01. Detection of Hepatocellular Carcinoma
GPC3 PET/CT enables highly specific detection of HCC lesions.
02. Accurate Tumor Staging
The scan helps determine the extent of disease within the liver and identifies spread to lymph nodes or distant organs, aiding precise staging.
03. Detection of Extrahepatic Metastases
GPC3 PET/CT can identify small metastatic deposits in lungs, bones, or lymph nodes that may be missed on routine imaging.
04. Assessment of Treatment Response
05. Selection for Targeted & Theranostic Approaches
GPC3 imaging helps identify patients who may benefit from GPC3-targeted therapies, radioligand treatments.
Subsribe To Our Newsletter
Stay in touch with us to get latest news and special offers.